Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JANUARY 17, 2023

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.6215?guestAccessKey=7d356e90-d727-4e31-9204-f3f2ff361aba&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011723

 

About The Study: The results of this study suggest that advanced colorectal neoplasm prevalence at screening colonoscopies conducted 10 or more years after a negative screening colonoscopy is low. Extension of the currently recommended 10-year screening intervals may be warranted, especially for female and younger participants without gastrointestinal symptoms. 

Authors: Thomas Heisser, M.Sc., of the German Cancer Research Center in Heidelberg, Germany, is the corresponding author.

 

(doi:10.1001/jamainternmed.2022.6215)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.